Industry Analysis & Industry Trends
Biotechnology is becoming an increasingly important part of product development in a variety of industries. Biotechnology refers to the use of living organisms, or their products, to modify human health and the human environment. While genetically modified products remain controversial, attitudes are beginning to change, with the increasing acceptance of the process within agricultural industries and across other sectors.
Biotechnology companies are often spin-offs, using research started in higher education, public and not-for-profit research organisations. While a large amount of biotech research and development is funded by selling company stock or from interest income, research in the industry is largely funded by government and non-profit organisations... purchase to read more
Industry Report - Industry Key Buyers Chapter
Biotech companies tend to be small enterprises with just one to a few compounds in development. Many of these companies operate at a loss given the length and cost of the R&D process. Thus the industry tends to be highly fragmented.
Australia's Biotechnology industry has a low level of market share concentration, with the top four players accounting for about 25.0% of the market. Industry firms range from the heavyweight CSL (which offers a range of commercialised products and generates billions in sales revenue), to foreign subsidiary pharmaceutical and agricultural companies (such as Amgen and Monsanto), to many small operations that are yet to commercialise any products and instead survive on research grants... purchase to read more